More recently a systematic review and meta-analysis on LCN2 in acute kidney injury (AKI) or failure investigating more than 50 studies concluded that blood LCN2 could be used as a diagnostic marker for AKI in newborns (Jiang and Cui, 2015). This evidence concerns the gene LCN2 and acute kidney injury.